Life Scientist > Biotechnology

Nanowires accelerate stem cells' transition into bone

25 July, 2022

Bone-forming stem cells grown on a mesh of these nanowires transform into mature bone much faster than is typical of other culturing conditions.

Diabetes drug to correct metabolic abnormalities

22 July, 2022

PATAS, part of a new class of antidiabetic drugs, can correct the metabolic abnormalities leading to type 2 diabetes and its associated comorbidities.

Spider venom treatment for heart attacks progressing to trials

07 July, 2022

The drug candidate uses a molecule found in the venom of the K’gari funnel-web spider, and can potentially prevent damage caused by heart attacks and stroke.

Existing drug may help treat spinal cord injury

17 June, 2022

Scientists have shown that an existing drug may reduce damage after spinal cord injury (SCI), by blocking the inflammatory response in the spinal cord.

Human ear reconstructed with 3D-bioprinted implant

08 June, 2022

AuriNovo is a patient-specific, living tissue implant created using 3D-bioprinting technology for surgical reconstruction of the outer ear in people born with microtia.

Damaged liver repaired, transplanted after 3 days outside body

06 June, 2022

Liver4Life reports the successful treatment of a damaged human liver for three days outside of the body, with implantation of the recovered organ into a cancer patient.

Wireless neurostimulator like a pacemaker for the brain

24 May, 2022

Neurological disorders like Parkinson's, chronic depression and other psychiatric conditions can now be managed at home.

Bringing clinical trials to the home: a game changer for the sector

23 May, 2022 by Edwin Ng, Senior Vice-President, Asia-Pacific for Medidata, a Dassault Systèmes company

COVID-19 has forced Australia's pharmaceutical and healthcare companies to completely redesign how clinical trials are run.

How do antidepressants treat nerve pain?

04 May, 2022

Knowing how pain impulses are inhibited by tricyclic antidepressants is expected to lead to new and improved treatment options.

Biobanking could save koalas from extinction

26 April, 2022

Biobanking and assisted reproduction could become a reality for koalas by leveraging the existing technology used to help humans conceive.

CA inhibitor drug reduces breathing pauses in sleep apnoea

21 April, 2022

Overall, the treatment reduced the number of breathing pauses and promoted oxygenation during the night.

Accelerating Australia's RNA Capabilities

19 April, 2022

It is one thing to invest into pure research, but to invest in a future that has, at its core, collaboration and accelerated development is a giant leap.

Creating a genetic medicine manufacturing ecosystem: part 3

07 April, 2022 by Peter Davis

A year ago, we were waiting for the federal government to deliver funding and a plan forward for a genetic medicine ecosystem.

'Trojan Horse' drug delivery system developed

05 April, 2022

Scientists created a method of delivering drugs into human cells using large biological molecules by first encasing them in a protein-based microdroplet.

Clinical trial commences for Melbourne-made COVID vaccines

29 March, 2022

Researchers are looking for 114 healthy people aged 18–70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd